Bionano Genomics (BNGO) Change in Acquisitions & Divestments (2021 - 2025)
Bionano Genomics (BNGO) has disclosed Change in Acquisitions & Divestments for 5 consecutive years, with $68.4 million as the latest value for Q4 2025.
- Quarterly Change in Acquisitions & Divestments rose 215.1% to $68.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $229.1 million through Dec 2025, down 25.36% year-over-year, with the annual reading at $229.1 million for FY2025, 25.36% down from the prior year.
- Change in Acquisitions & Divestments hit $68.4 million in Q4 2025 for Bionano Genomics, up from $56.2 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $158.2 million in Q1 2024 to a low of $16.9 million in Q1 2023.
- Historically, Change in Acquisitions & Divestments has averaged $53.4 million across 5 years, with a median of $51.4 million in 2023.
- Biggest five-year swings in Change in Acquisitions & Divestments: soared 836.58% in 2024 and later plummeted 67.95% in 2025.
- Year by year, Change in Acquisitions & Divestments stood at $66.5 million in 2021, then dropped by 1.48% to $65.5 million in 2022, then decreased by 20.38% to $52.2 million in 2023, then plummeted by 58.4% to $21.7 million in 2024, then skyrocketed by 215.1% to $68.4 million in 2025.
- Business Quant data shows Change in Acquisitions & Divestments for BNGO at $68.4 million in Q4 2025, $56.2 million in Q3 2025, and $53.9 million in Q2 2025.